期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Hypertrophic cardiomyopathy:current understanding and emerging therapeutics
1
作者 Jia-Qi Dai Da Zhu +2 位作者 Maurizio Taramasso Xiang-Bin Pan Dao-Wen Wang 《Medicine Plus》 2025年第1期1-7,共7页
Hypertrophic cardiomyopathy(HCM)is one of the most common inherited cardiovascular diseases,with a global prevalence estimated at 0.2%to 0.5%.1 It is characterized by left ventricular hypertrophy which could not be ex... Hypertrophic cardiomyopathy(HCM)is one of the most common inherited cardiovascular diseases,with a global prevalence estimated at 0.2%to 0.5%.1 It is characterized by left ventricular hypertrophy which could not be explained by abnormal loading conditions,and a considerable proportion of patients were accompanied by either resting or inducible left ventricular outflow tract(LVOT)obstruction,leading to impaired cardiac function,mitral regurgitation due to systolic anterior motion(SAM)condition,with subsequent reduced quality of life,adverse clinical outcomes or even sudden death(Supplementary Text 1 online).2 HCM was previously believed to exhibit an autosomal dominant inheritance pattern,typically caused by pathogenic mutations in genes encoding sarcomeric proteins,with MYBPC3 and MYH7 being the most commonly involved genes.3 However,about 60%of all patients test negative for sarcomeric variants,4 suggesting a possible polygenic inheritance pattern in these patients and the contribution of non-genetic factors on disease phenotype(Supplementary Text 2 online). 展开更多
关键词 left ventricular hypertrophy impaired cardiac functionmitral regurgitation hypertrophic cardiomyopathy hcm systolic anterior motion sam conditionwith pathogenic mutations sarcomeric proteins hypertrophic cardiomyopathy autosomal dominant
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部